Provention Bio - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsProvention Bio

Provention Bio(PRVB)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Tzield	Teplizumab	2022-11-17		Type 1 diabetes mellitus

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

,

pigmented villonodular synovitis

,

giant cell tumor of tendon sheath

non-hodgkin lymphoma

,

,

hodgkin disease

,

rheumatoid arthritis

,

Globulin, immune

triple negative breast neoplasms

,

healthy volunteers/patients

,

pelvic neoplasms

,

pancreatic ductal carcinoma

,

cutaneous malignant melanoma

,

central nervous system neoplasms

,

second primary neoplasms

,

plasma cell neoplasms

,

cholangiocarcinoma

,

neoplasms by site

,

head and neck neoplasms

,

pancreatic neoplasms

,

squamous cell carcinoma of head and neck

,

prostatic neoplasms

,

renal cell carcinoma

,

endometrial neoplasms

,

,

,

mantle-cell lymphoma

,

,

ureteral neoplasms

,

esophageal neoplasms

,

large b-cell lymphoma diffuse

,

follicular lymphoma

,

uterine cervical neoplasms

,

biliary tract neoplasms

,

b-cell lymphoma marginal zone

,

malignant mesothelioma

,

,

squamous cell carcinoma

,

squamous cell neoplasms

,

laryngeal diseases

,

multiple myeloma

,

waldenstrom macroglobulinemia

,

,

,

malignant pleural effusion

,

thyroid diseases

,

mucinous adenocarcinoma

,

,

synovial sarcoma

,

desmoplastic small round cell tumor

,

carcinoid tumor

,

brain neoplasms

,

,

,

gastrointestinal stromal tumors

,

diabetic nephropathies

,

kidney diseases

,

multiple sclerosis

,

relapsing-remitting multiple sclerosis

,

,

interdigitating dendritic cell sarcoma

,

,

thymus neoplasms

,

oropharyngeal neoplasms

,

adolescent development

,

castration-resistant prostatic neoplasms

,

extranodal nk-t-cell lymphoma

,

adenocarcinoma of lung

,

bronchiolo-alveolar adenocarcinoma

,

esophageal squamous cell carcinoma

,

kidney neoplasms

,

systemic lupus erythematosus

,

inflammatory bowel diseases

,

reactive arthritis

,

non-small-cell lung carcinoma

,

,

colorectal neoplasms

,

neoplasm metastasis

,

breast neoplasms

,

,

,

stomach neoplasms

,

ovarian neoplasms

,

rectal neoplasms

,

liver neoplasms

,

,

colonic neoplasms

,

hepatocellular carcinoma

,

non-hodgkin lymphoma

,

urinary bladder neoplasms

,

alzheimer disease

,

b-cell chronic lymphocytic leukemia

,

b-cell lymphoma

,

fallopian tube neoplasms

,

diabetes mellitus

,

ulcerative colitis

,

,

,

urologic neoplasms

,

,

,

ischemic stroke

,

,

peritoneal neoplasms

,

urethral neoplasms

,

type 1 diabetes mellitus

,

carotid stenosis

,

transitional cell carcinoma

,

ankylosing spondylitis

,

small cell carcinoma

,

small cell lung carcinoma

,

,

gastrointestinal neoplasms

,

digestive system neoplasms

,

gastrointestinal diseases

,

digestive system diseases

,

colonic diseases

,

intestinal diseases

,

hematologic diseases

,

pathologic constriction

,

,

,

juvenile arthritis

,

rectal diseases

,

intestinal neoplasms

,

intracranial hemorrhages

,

,

,

,

lymphoid leukemia

,

coronavirus infections

,

,

type 2 diabetes mellitus

,

rheumatoid arthritis

,

myocardial infarction

,

psoriatic arthritis

,

,

,

,

spondylarthritis

,

,

cardiogenic shock

,

coronary artery disease

,

,

trigeminal neuralgia

,

glossopharyngeal nerve diseases

,

intermediate uveitis

,

anterior uveitis

,

posterior uveitis

,

,

healthy volunteers/patients

,

systemic lupus erythematosus

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use